News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Arndt Vogel: 1L Nivo Plus Low-Dose Ipi Shows Promising Results in MSI Advanced Gastric Cancer
Collage photo of Arndt Vogel and Hisato Kawakami
Jun 30, 2025, 08:38

Arndt Vogel: 1L Nivo Plus Low-Dose Ipi Shows Promising Results in MSI Advanced Gastric Cancer

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared a post on X about a paper by Hisato Kawakami et al. published in the Journal of Clinical Oncology:

“First-Line Nivo plus Low-Dose Ipi for MSI Advanced Gastric or Esophagogastric Junction Cancer
Phs II NO LIMIT
  • ORR 62.1%, 10.3% CR, DCR 79.3%
  • mPFS 13.8 mo
  • gr ≥3 TRAEs 37.9%
  • interesting translational program.”

Title: Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer

Authors: Hisato Kawakami, Shigenori Kadowaki, Akitaka Makiyama, Masahiro Tsuda, Kenro Hirata, Naotoshi Sugimoto, Nozomu Machida, Hiroki Hara, Hidekazu Hirano, Taito Esaki, Yoshito Komatsu, Shuichi Hironaka, Yukari Kobayashi, Kazuhiro Kakimi, Yasutaka Chiba, Narikazu Boku, Ichinosuke Hyodo, Kei Muro.

You can read the Full Article in the Journal of Clinical Oncology.

Arndt Vogel: 1L Nivo Plus Low-Dose Ipi Shows Promising Results in MSI Advanced Gastric Cancer

More posts featuring Arndt Vogel.

Akitaka Makiyama Arndt Vogel cancer Esophagogastric Junction Cancer gastric cancer Hidekazu Hirano Hiroki Hara Hisato Kawakami Ichinosuke Hyodo Kazuhiro Kakimi Kei Muro Kenro Hirata Masahiro Tsuda Naotoshi Sugimoto Narikazu Boku Nozomu Machida OncoDaily Oncology Shigenori Kadowaki Shuichi Hironaka Taito Esaki Yasutaka Chiba Yoshito Komatsu Yukari Kobayashi
Special Coverage
Science
Jun 30, 2025, 08:38
Arndt Vogel: 1L Nivo Plus Low-Dose Ipi Shows Promising Results in MSI Advanced Gastric Cancer
Opinion
Jun 30, 2025, 08:32
Edward Christopher Dee Reflects on Mentorship from Anthony D’Amico at Memorial Sloan Kettering
Blog
Jun 30, 2025, 08:27
Vicki Durston: Thrilled to Share Insights from MASCC 2025
Insight
Jun 30, 2025, 08:17
Jeff Yang Highlights Study on Lung Screening Access via Potter Criteria in JAMA Network Open
Blog
Jun 30, 2025, 08:06
Paolo Tarantino: Our ADC Toxicity Review Has Been Highlighted at MASCC 2025
Blog
Jun 30, 2025, 08:00
SIO to Host Pre-Conference Workshop on Music Therapy in Oncology Care
Blog
Jun 30, 2025, 07:59
Liz O’Riordan: The Terrifying Rise of Alternative Cancer Coaches - And The Nonsense They Told me to Do to Cure My Cancer
Blog
Jun 30, 2025, 07:47
Nataliya Kovalchuk Expresses Gratitude for Teaching Award Recognition
Insight
Jun 30, 2025, 07:38
Progress Made, But More Action Needed: João Breda's Message at the ELLOK 2nd Synergies Forum on Cancer Care
Blog
Jun 30, 2025, 07:38
AACR25 Session Recordings Available On-Demand Through October 31
Blog
Jun 30, 2025, 07:22
Petros Grivas: Grateful for Another Amazing Athens Meeting With Top Scientific and Social Agenda
Blog
Jun 30, 2025, 07:09
Katie Coleman Marks Four-Year Milestone After Surviving Rare Stage IV Cancer at 29